arrow_back Back to App

Access to Taxpayer-Funded Medicines and Vaccines

This act aims to increase access to drugs, vaccines, and medical technologies developed with Department of Defense funding. Citizens may gain easier access to these products as the Department of Defense will be required to authorize other entities to use them. Additionally, a public database will be created to show how taxpayer money is used for medical research.
Key points
Increased Access to Medicines and Vaccines: The Department of Defense must make at least 10 medical products (drugs, vaccines, technologies) developed with its support available to expand access for military and civilians.
Transparency of Spending: A public, easily accessible database will be created to show which medical research is funded by the Department of Defense, including information on costs, companies, and product prices.
Company Accountability: Companies that received Department of Defense support will be required to disclose information about their research and products, with financial penalties for non-disclosure.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_4757
Sponsor: Rep. Doggett, Lloyd [D-TX-35]
Process start date: 2021-07-28
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Make Taxpayer-Funded Department of Defense Medical Interventions Affordable Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_4757.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-07-28.

What are the main provisions?

Key points include:

  • Increased Access to Medicines and Vaccines: The Department of Defense must make at least 10 medical products (drugs, vaccines, technologies) developed with its support available to expand access for military and civilians.
  • Transparency of Spending: A public, easily accessible database will be created to show which medical research is funded by the Department of Defense, including information on costs, companies, and product prices.
  • Company Accountability: Companies that received Department of Defense support will be required to disclose information about their research and products, with financial penalties for non-disclosure.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Doggett, Lloyd [D-TX-35].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health Public Investments